ORA - Oxford University Research Archive

1 - 9 of 9

1

Conference item

Interaction of type 2 cytotoxic T lymphocytes and mast cell lipid mediators contributes to pathogenesis of eosinophilic asthma

Conference abstract
Xue, L, Stoeger, L, Marchi, E, et al.
2017-05-23

2

Conference item

Type-2 CD8+ T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma

abstract
Hinks, T, Hilvering, B, Stoger, L, et al.
2018-11-19

3

Conference item

Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)

Xue, L, Chen, W, Luo, J, et al.
2019-05-22

4

Conference item

Sputum Il-17a levels correlate with biomarkers of non-eosinophilic inflammation in patients with asthma

Conference abstract
Hynes, G, Go, S, Thulborn, SJ, et al.
2017-05-23

5

Conference item

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

Chen, W, Hardman, C, Batty, P, et al.
2018-11-19

6

Conference item

Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells

Conference abstract
Xue, L, Hardman, C, Chen, W, et al.
2018-12-01

7

Conference item

The effect of oral corticosteroids on circulating type-2 cytokine producing cells in patients with severe eosinophilic asthma

Conference abstract
Hynes, G, Go, S, Luo, J, et al.
2018-12-01

8

Conference item

Effects of steroids in cultured human type-2 cytokine producing cells

Conference abstract
Luo, J, Go, S, Stoger, L, et al.
2018-12-01

9

Conference item

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

Xue, L, Hardman, C, Chen, W, et al.
2019-03-14

TO TOP